CDKN2A and neoplasm: Case 2 (patient ID 501) is a 68-year-old man with metastatic gastrointestinal stromal tumor with BRAF V600E and CDKN2A alterations (30), who presented after the tumor progressed on BRAF/MEK-targeted therapy.